Pitcher, AlexAlexPitcherSpata, EntiEntiSpataEmberson, JonathanJonathanEmbersonDavies, KellyKellyDaviesHalls, HeatherHeatherHallsHolland, LisaLisaHollandWilson, KateKateWilsonReith, ChristinaChristinaReithChild, Anne HAnne HChildClayton, TimTimClaytonDodd, MatthewMatthewDoddFlather, MarcusMarcusFlatherJin, Xu YuXu YuJinSandor, GeorgeGeorgeSandorGroenink, MaartenMaartenGroeninkMulder, BarbaraBarbaraMulderDe Backer, JulieJulieDe BackerEvangelista, ArturoArturoEvangelistaForteza, AlbertoAlbertoFortezaTeixido-Turà, GiselaGiselaTeixido-TuràBoileau, CatherineCatherineBoileauJondeau, GuillaumeGuillaumeJondeauMilleron, OlivierOlivierMilleronLacro, Ronald VRonald VLacroSleeper, Lynn ALynn ASleeperChiu, Hsin-HuiHsin-HuiChiuMEI-HWAN WUNeubauer, StefanStefanNeubauerWatkins, HughHughWatkinsDietz, HalHalDietzBaigent, ColinColinBaigent2023-11-102023-11-102022-09-1001406736https://scholars.lib.ntu.edu.tw/handle/123456789/637089Angiotensin receptor blockers (ARBs) and β blockers are widely used in the treatment of Marfan syndrome to try to reduce the rate of progressive aortic root enlargement characteristic of this condition, but their separate and joint effects are uncertain. We aimed to determine these effects in a collaborative individual patient data meta-analysis of randomised trials of these treatments.enjournal article10.1016/S0140-6736(22)01534-3360494952-s2.0-85137288244https://api.elsevier.com/content/abstract/scopus_id/85137288244